MENU
SAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
408.91M
P/E Ratio
N/A
Total Cash
423.85M
Projected Growth
N/A
Total Debt
11.86M
Revenue
47.4M
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash/Share
6.77
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price
Fundamentals
SAGE
Capitalization
409M
P/E Ratio
N/A
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash
424M
Total Cash/Share
6.77
Total Debt
11.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.77%
Revenue
47.4M
ROE
N/A
Book Value
410M
P/B Ratio
1.00
Cash Flow
N/A
Earnings
-5.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
9.13
Current Revenue Per Employee
28876.80
Dividends Per Share - Security
N/A
EBITDA
-358.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.34
Revenue To Assets
-57.29
Shares Held By Institutions
399M
Shares Outstanding - Current
62.6M
Total Liabilities
59.8M
Total Volume MTD
N/A
Value
1
Gain YTD
20.258
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and medicines for central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com